Research & Development
FDA approves Sanofi's subcutaneous Sarclisa Escena as first anticancer therapy delivered via on-body injector
10 July 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Friday that the US Food and Drug Administration (FDA) has approved the company's subcutaneous S...
Accord BioPharma's second pegfilgrastim biosimilar to NEULASTA approved by US FDA
10 July 2026 - Accord BioPharma, the US specialty division of India-based Intas Pharmaceuticals Ltd, focused on the development of oncology, immunology, and central nervous system (CNS) therapies, ann...
BiBBInstruments signs first European distribution deal for EndoDrill GI with Palex Spain
10 July 2026 - Swedish cancer diagnostics company BiBBInstruments AB (Spotlight Stock Market: BIBB) said on Thursday it has signed its first European commercial distribution agreement for its powered ...
Vector Science and Therapeutics names Darryl Drake Jr. president of Valor athlete and performance division
9 July 2026 - Vector Science and Therapeutics Corp (TSXV:PAIN), a pharmaceutical-grade peptide and precision drug delivery company, announced on Wednesday the appointment of Darryl Drake Jr. as presid...
Invictus Pharmacy and Mullan Pharmaceutical partner to expand patient access to Ganirelix Acetate Injection
8 July 2026 - Invictus Pharmacy, a pharmacy platform managed by Invictus Ventures Inc, and Mullan Pharmaceutical Inc, a pharmaceutical company focused on expanding access to FDA-approved medications t...
Vanda Pharmaceuticals' investigational therapy for Charcot-Marie-Tooth disease type 2S granted FDA Rare Pediatric Disease Designation
8 July 2026 - US pharmaceutical company Vanda Pharmaceuticals Inc (Nasdaq:VNDA) announced on Tuesday that the US Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to VC...